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Abstract
Background: The incidence and mortality from prostate cancer is expected to increase in the next decade in
Thailand. Despite the perceived lower risk in this population vs. developed, western countries, it is becoming an
important public health issue. Prostate cancer incidence varies between the most predominant religious groups in
Thailand, Buddhists and Muslims. However limited data is available describing the prostate cancer survival in these
two populations. Here we examine differences in prostate tumor characteristics and survival between Buddhists and
Muslims in the province of Songkhla, Thailand.
Methods: 945 incident prostate cancer cases (1990–2014) from the population-based Songkhla Cancer Registry
were used in this analysis. Age, grade, stage, and year at diagnosis were compared across religious groups, using
Wilcoxon or Chi-square tests. Kaplan Meier methods were used to estimate the median survival time and 5-year
survival probabilities. Cox proportional hazards models were used to estimate hazard ratios (HR) between religious
groups and 95% confidence intervals (CI) for mortality in age-adjusted and fully-adjusted models.
Results: Prostate tumor characteristics, age, and year at diagnosis were similar across religious groups. The median
survival time after diagnosis of prostate cancer was longer in Buddhists 3.8 years compared with Muslims 3.2 years
(p = 0.08). The age-adjusted risk of death after prostate cancer diagnosis was higher in Muslims compared with
Buddhists (HR: 1.31; 95%CI: 1.00, 1.72). After adjustment by stage and grade, results were slightly attenuated
(HR: 1.27, 95%CI: 0.97, 1.67).
Conclusion: Muslims have shorter survival after prostate cancer diagnosis than do Buddhists in Thailand. The
reasons underlying this difference require additional investigation in order to design targeted interventions for
both populations.
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Background
Worldwide, the overall burden of prostate cancer has
increased substantially over the last three decades, with
geographical variation in incidence and mortality [1–3].
The highest incidence rates of prostate cancer are ob-
served in Western, developed countries such as the
United States (US), (age-standardized incidence rate
(ASR): 98.2 prostate cancer cases per 100,000
person-years) [4]. This high incidence can be partially
explained by the implementation of population-based
screening programs using the prostate-specific antigen
(PSA) test in the US population [5]. However, even
Western developed countries that do not conduct
population-based PSA screening have relatively high in-
cidence rates of prostate cancer (e.g. Canada: 88.9 and
the UK: 73.2 prostate cancer cases per 100,000
person-years) [4]. On the other hand, incidence rates of
prostate cancer are relatively low in non-Western, less
developed regions such as South-East Asia (ASR: 5.5
prostate cancer cases per 100,000 person-years) [4].
Despite these current lower rates in South-East Asia,
the burden of disease is expected to increase in this
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region and other low and middle income countries
worldwide [1, 2, 6–8]. In Thailand, prostate cancer is the
fourth most common diagnosed cancer and the fourth
leading cause of cancer death among Thai men [4]. In
southern Thailand, incidence and mortality rates of
prostate cancer have increased significantly from 1990 to
2013 at an estimated annual percent change of 4.8 and
5.3% respectively [9]. In addition, prostate cancer rates
are projected to continue increasing through 2030,
doubling the rates observed in 2013 [9].
Unlike the lower incidence rates in Southeast Asia,
prostate cancer mortality rates are relatively high
(ASMR: 6.7 deaths per 100,000 person-years) [4]; the
mortality-to-incidence ratio (MIR) in Thailand is 0.51,
compared to more developed countries such as the US
(MIR: 0.09) [9, 10]. The lower survival rates of prostate
cancer in many Asian countries is consistent with the
large proportion of prostate cancer diagnosed at ad-
vanced stages, mostly due by the lack of PSA screening
[11, 12]. However, we cannot rule out other factors, such
as genetics, access to care, and sociocultural characteris-
tics of Asian populations that may influence disparities
in prostate cancer outcomes not only between- but also
within- countries [13].
Songkhla is a province in southern Thailand, located
on the eastern side of the Malay Peninsula [14]. It has
16 districts with a population of 1.5 million inhabitants
[15]. The composition of the population in Songkhla is
unique because of the diversity in ethnic/religious
groups [14]. Approximately, 25% of the people are
Muslims and 75% Buddhists. There are documented
health disparities between Buddhists and Muslims in
Songkhla, Thailand. These differences are thought to be
due, in part, to variability in lifestyle factors because of
cultural differences between these groups [16, 17]; for
example, studies have reported differences in risk of
cancer at several sites, including prostate cancer, as well
as differences in risk of other chronic diseases and risk
factors, such as metabolic syndrome, cardiovascular dis-
eases and diabetes [17–19]. Prostate cancer incidence
rates in Muslims are lower compared to Buddhists
(ASR: 8.7 prostate cancer cases per 100,000 person-years
in Buddhists vs < 5 in Muslims) [17]. However, to our
knowledge, no studies have examined if these differences
extend to differential cancer survival between these two
religious groups. Therefore, the purpose of our study
was to compare the prostate tumor characteristics and
the survival time after diagnosis with prostate cancer
between Buddhist and Muslim men in Songkhla, Thailand.
Methods
Study population
We extracted incident prostate cancer cases from the
Songkhla Cancer Registry (SCR) from 1989 to 2014.
A detailed description of this registry has been pro-
vided elsewhere [20, 21]. Briefly, the SCR is a
population-based cancer registry that has actively col-
lected cancer cases in the Songkhla province since
1989. It captures cancer cases from 23 data sources,
including governmental and private hospitals as well
as the population registration office [20, 21]. The SCR
also collects information on age and year at diagnosis,
religion, stage, grade as well as date of last contact,
date of death, and vital status. The completeness of
case ascertainment is greater than 95%, evaluated by
capture-recapture methods [22]. This registry delivers
high quality data and has contributed data to the
International Agency for Research on Cancer (IARC),
Cancer Incidence in Five Continent publications since
volume VIII [23].
Data extraction and variables
The 10th revision of the International Classification of
Disease (ICD-10) code for malignant neoplasm of the
prostate (C61) was used for the extraction of prostate
cancer cases. We restricted our analysis to prostate
cancer cases diagnosed after 1989, because we assumed
that data was incomplete during the first year of
registration. In total, 945 prostate cancer cases were
diagnosed between January 1, 1990 and December 31,
2014. We further excluded four prostate cancer cases
because of missing information on religion.
Religious group (Buddhist or Muslim) is routinely
collected in the SCR. Age at diagnosis is recorded as
continuous variable (in years). We categorized grade as
moderately/poorly differentiated, undifferentiated, or
unknown; and stage as localized/regional, distant and
unknown. Age at diagnosis was categorized in 5-year
groups (e.g. 1990–1994, 1995–1999, 2000–2004, 2005–
2009 and 2010–2014). In addition, vital status is re-
corded as dead or alive. Deaths are ascertained for
cancer cases included in the registry through abstraction
of vital statistics records, regular scrutiny of hospital
records as well as linkage with the referral system and
with public and private health care providers [23]. The
deaths represent all-cause mortality, not prostate
cancer-specific mortality.
Statistical analysis
Age at diagnosis and prostate tumor characteristics such
as grade and stage, as well as year at diagnosis were
compared between Buddhists and Muslims. We used the
Wilcoxon test to compare median age at diagnosis be-
tween the two religious groups, as age was not normally
distributed. The chi-squared test was used to compare
the distribution of prostate cancer cases by grade, stage
and year at diagnosis in Buddhists and Muslims. All tests
were considered statistically significant at p < 0.05.
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The main outcome of interest was survival time, de-
fined as the number of years between date of diagnosis
and either date of death or date of last contact. Median
survival time as well as 5-year survival probability of
prostate cancer were estimated using the Kaplan-Meier
method, and differences by religious group were assessed
using the log-rank test. Kaplan-Meier survival curves of
prostate cancer were obtained for the overall study
population and stratified by religious group. To confirm
the proportional hazard assumption, we examined
Kaplan-Meier plot of survival (S) versus time (T) and
log (−log(S)) versus log (T) for Buddhists and Muslims,
finding that there was no evidence of violation of the
proportional hazard assumption from visual inspection
of the survival functions for exposure groups. Further,
we included an interaction term between religious group
and follow-up time and evaluated its significance using
the Wald test; this variable was not statistically signifi-
cant (p = 0.76).
Cox proportional hazard models were used to estimate
the hazard ratio (HR) and 95% confidence interval (CI)
for mortality. The main exposure considered was reli-
gious group as recorded in the registry (Buddhist or
Muslim). Models were compared with and without using
the following covariates in the model: age, and tumor
grade and stage. In addition, we assessed for interaction
between religious group and age, grade and stage using
product terms. All statistical analyses were conducted in
SAS software v 9.4 (SAS Institute, Cary NC).
Sensitivity analysis
Because of the large number of unstaged and ungraded
tumors (78.9 and 46.9%, respectively), we conducted a
multiple imputation analysis to impute stage and grade
for those missing this information, including age, reli-
gion, follow-up time and vital status to predict the miss-
ing data. We used the PROC MI statement in SAS to
conduct the multiple imputation. We obtained param-
eter estimates from the multivariable-adjusted Cox
proportional hazards regression models for 100 imputed
datasets. The parameter estimates were combined for
inference using PROC MIANALYZE statement in
SAS. We assumed that data were missing completely
at random.
To evaluate the effect of period pre- and
post-introduction of the universal health coverage by the
Thai National Health Office in the early 2000s we exam-
ined the religious group-specific median survival time,
12-months, 2- and 5-year survival probabilities, parti-
tioning follow up time as follows: 1990–1999, 2000–
2004, 2005–2009 and 2010–2014. Finally, to more
tightly control for age and calendar year, we conducted
sensitivity analyses using age and calendar year as the
time scale in our models.
Results
Of the 945 prostate cancer cases, 89.2% were Buddhists
and the rest Muslims, with a median age at diagnosis of
74 (Interquartile range (IQR) = 67, 79) and 72 (IQR = 68,
77) respectively (Table 1). Of tumors with known grade
at diagnosis the majority were moderately/poorly differ-
entiated. Similarly, among tumors with known stage at
diagnosis, the majority were distant. In addition,
Muslims seem to have a slightly higher proportion of
undifferentiated and distant tumors compared to
Buddhists. On the other hand, the proportion of
ungraded and unstaged tumors is slightly higher in
Buddhists compared to Muslims. Furthermore, more
than 80% of the cases have been diagnosed since the
year 2000 when universal health coverage was intro-
duced in Thailand. We observed no statistically signifi-
cant differences by religious group for any of the
variables examined (Table 1). Age at diagnosis did not
differ across categories of stage, grade and year of
diagnosis (p-values: 0.71, 0.08 and 0.57, respectively), and,
as expected, higher grade and stage tumors were statisti-
cally significantly more likely to die (data not shown).
The overall median survival time after diagnosis of
prostate cancer was 3.7 years (95%CI: 3.4, 4.2), and
the overall 5-year survival probability was 40.6%
(95%CI: 37.0, 44.2) (Fig. 1). Despite the small number
of Muslim prostate cancer cases (n = 98), we found a
borderline significant difference in prostate cancer
survival between Buddhists and Muslims (log-rank
test, p = 0.08). The median survival time was longer
in Buddhists 3.8 years (95%CI: 3.4, 4.3) compared to
Muslims 3.2 years (95%CI: 2.0, 4.4) (Fig. 2, and
Table 2). Similarly, Buddhists have a higher 5-year
survival probability of prostate cancer than Muslims,
41.3% (95%CI: 37.4, 45.0) vs 34.7% (95%CI: 23.8,
45.8), respectively (Table 2).
We next estimated differences in survival after diagno-
sis between religious groups. After adjustment for age at
diagnosis, Muslim men were more likely to die of any
cause post-diagnosis with prostate cancer compared to
Buddhist men (HR: 1.31, 95%CI: 1.00, 1.72; p = 0.04).
This finding was only slightly attenuated after further
adjustment for stage and grade at diagnosis (HR: 1.27,
95%CI: 0.97, 1.67; p = 0.06). There was no evidence of
statistically significant interactions between religious
group and age (p = 0.64), grade (p = 0.22) or stage at
diagnosis (p = 0.29). In addition, our multiple imputation
analysis from 100 imputed datasets yielded similar re-
sults for the multivariable-adjusted Cox regression
model, the estimated HR for death in Muslims vs
Buddhists was 1.28 (95%CI: 0.97, 1.66). Furthermore,
the overall stage distribution and by religious groups
remain similar after multiple imputation (Additional
file 1: Table S1).
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Estimates from the overall median survival time (years)
by period after partitioning follow-up time show that
although overall, there are modest increases in the median
survival time and 12-months, 2- and 5-years survival
probabilities pre- and post- introduction of universal
health access, these increases appear limited to Buddhist
men. The 1-year survival probability increases from 77.9%
in 1990–1999 to 83.6% in 2010–2014 in Buddhists. On
the other hand, among Muslims the 1-year survival prob-
ability remained unchanged during 1990–1999: 75.0% and
2010–2014: 75.5% (Table 3). Finally, the three methods
used to account for time (person-years, calendar time, and
age) yielded similar results in both the age-adjusted and
fully-adjusted models (Table 4).
Discussion
We compared prostate cancer characteristics and sur-
vival after diagnosis between Muslim and Buddhist men
in Songkhla, Thailand. We found that Muslim men had
a higher risk of death after diagnosis of prostate cancer
compared to Buddhists, finding which was not fully
explained by differences in tumor characteristics at
diagnosis. However, the large number of unstaged and
ungraded tumors in both groups does not allow for
complete adjustment for these factors even when imput-
ation was used to attempt to assign stage and grade to
those with missing information. Differences in the distri-
bution of tumor characteristics among those with
missing information by religious groups might still
explain the observed survival differences.
Overall, the percent of people surviving five years after
diagnosis of prostate cancer is lower in Thailand (40.6%)
compared to more developed countries such as the US
(98.9%). This is partially explained by the widespread use
of PSA screening in the US. In Thailand, PSA is not
used for screening purposes, although, it is part of the
diagnostic workup in patients with suspected prostate
cancer. Other factors such as sociocultural characteris-
tics and genetics may explain the differences in prostate
cancer outcomes. Importantly, differences in life expect-
ancy between Thailand and more developed countries
such as the US is unlikely to explain the difference in
survival as the life expectancy in Thai males is close to
the US males (72.0 vs 76.1 years) [15, 24].
Our findings are consistent with those from several
published studies that suggest that Muslim populations
have poorer cancer survival after diagnosis compared to
other ethnic and religious groups [23, 25–29]. In
Songkhla, Thailand, lower survival rates for oral, breast
and cervical cancer have been observed among Muslims
compared to Buddhists [25]. Another study conducted
in Asian populations found that breast cancer survival is
higher among Indian (54%) and Chinese (49%) women
compared to Malay women (45%), which is a predomin-
antly Muslim population [26]. In addition, Malay women
are more likely to be diagnosed at advanced stages of








Buddhists n = 843
n (%) or
Median (Q1-Q3)




Age 73 (67,79) 74 (67,79) 72 (68, 77) 0.38
Grade
Well differentiated 186 (19.7) 163 (19.3) 23 (23.5) 0.65
Moderately/Poorly
differentiated
247 (26.1) 221 (26.2) 26 (26.5)
Undifferentiated 69 (7.3) 60 (7.1) 9 (9.2)
Unknown 443 (46.9) 399 (47.3) 40 (40.8)
Stage
Localized/Regional 50 (5.3) 42 (5.0) 8 (8.2) 0.35
Distant 149 (15.8) 132 (15.7) 17 (17.4)
Unknown 746 (78.9) 669 (79.4) 73 (74.5)
Year of diagnosis
1990–1999 177 (18.7) 155 (18.4) 21 (21.4) 0.75
2000–2004 147 (15.6) 133 (15.8) 14 (14.3)
2005–2009 264 (27.9) 237 (28.1) 25 (25.5)
2010–2014 357 (37.8) 318 (37.7) 38 (38.8)
aThere were 4 missing values for the religious group variable (n = 941)
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breast cancer than other ethnic/religious groups [27]. It
should be noted that the Muslims in Songkhla, Thailand
are predominantly of Malay descent. Similarly, a study
conducted in Northern Israel found that Arab women
are more likely to be diagnosed at advanced stage for
breast cancer, and with more aggressive disease com-
pared to their Jewish counterparts, likely due to differ-
ences in genetic susceptibility as well as socioeconomic
factors [28]. In the US, a prostate cancer survival study
found that risk of death after diagnosis of the disease is
40% higher among South Asian men compared to
Whites [30].
It remains unclear why Muslims may experience
poorer cancer outcomes. In Thailand, access to health-
care is relatively consistent across the country, and there
are ongoing efforts to integrate Muslims in Songkhla
into communities along with Buddhists. The Thai gov-
ernment has established policies for cultural assimilation
of minority religious groups (e.g. promotion of Thai
language and identity). However, there has been resistance
to these policies, and cultural differences do persist. For
example, some Muslims in southern Thailand speak Yawi
(a Malay dialect) as their first language, creating barriers
to communicating with healthcare providers who largely
speak Thai [25]. In addition, cultural beliefs could be an
important barrier for individuals to seek and/or receive
healthcare [31]. This may cause delay in diagnosis and
treatment for cancer. For example, one study found that
Thai Muslims experienced delays in the time from diagno-
sis to treatment for oral cancer compared to Buddhists,
which the authors concluded was likely due to differences
in health attitudes, among Muslims in Thailand [32, 33].
Another study that evaluated knowledge and health
belief attitudes for oral cancer among Thai Muslims
found that they are more likely to use traditional
medicine to prevent and treat oral cancer, even if
diagnosis of oral cancer was confirmed in a hospital
setting [33].
Several studies have reported that the perspectives of
sickness and death among Muslims are different than
Fig. 1 Kaplan-Meier survival curve of prostate cancer in Songkhla, Thailand. Footnote: Overall median survival time: 3.7 (95%CI: 3.4, 4.2). Overall
probability surviving after 5 years: 40.6% (95%CI: 37.0, 44.2)
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other religious groups [34]. In some studies about health
attitudes and knowledge, Muslims have reported a per-
ception of sickness as a God’s proof of their faithfulness
[35]. This belief may lead individuals to delay seeking
medical care for their cancer, which may partially ex-
plain the poorer survival from prostate cancer among
Muslim men in Songkhla. Anecdotal evidence from phy-
sicians practicing in Songkhla, Thailand suggests that
Muslims may be less likely to accept treatment after a
diagnosis with cancer, despite having equal access to
high quality care. Supporting this, our findings have
shown that survival has not improved among Muslims
after the introduction of universal health care. Although,
reports from a recent WHO report (CONCORD-3)
show that prostate cancer survival in Thailand appear to
increase by 10% from 1995 to 2014 [36]. In addition, the
risk of death after prostate cancer diagnosis appear to
increase in Muslims compared to Buddhists after the
introduction of the universal healthcare access, e.g.
1990–1999 HR: 0.96, 95%CI: 0.21, 4.19; 2010–2014 HR:
1.52, 95%CI: 1.00, 2.30 (Additional file 1: Table S2).
However, this increase is not statistically significant and
Fig. 2 Kaplan Meier survival curves of prostate cancer by religious group in Songkhla, Thailand. Footnote: Log-rank p value: 0.08













Model 1 Model 2
HR (95%CI) HR (95%CI)
Buddhists 520 3020.4 3.8 (3.4, 4.3) 41.3% (37.4, 45.0) 1.00 (ref) 1.00 (ref)
Muslims 62 279.4 3.2 (2.0, 4.4) 34.7% (23.8, 45.8) 1.31 (1.00, 1.72) 1.27 (0.97, 1.67)
Model 1: Adjusted by age
Model 2: Adjusted by age, grade and stage
Alvarez et al. BMC Cancer         (2018) 18:1175 Page 6 of 9
the number of deaths were small for the earliest period.
One possible concern is that if competing risks from
other causes of death differ by religious group, this may
bias our findings. However, studies comparing chronic
disease risk factors between Muslims and Buddhists in
Thailand have noted few differences in risk factor pro-
files by religion [18, 19] . Thus, competing risks seems
unlikely to fully explain our findings. Further research is
warranted to identify what factors may play a role in the
increased risk of death among Muslim men diagnosed
with prostate cancer in Thailand and whether similar
disparities in cancer survival exist for other cancer sites
or chronic conditions.
Strengths and limitations
Our findings are based on a high quality population-based
cancer registry, which allows us to extrapolate the re-
sults to the province of Songkhla and the rest of
southern Thailand; in addition the completeness of
follow up for this cancer registry is very high (> 95%)
[22]. Another strength is that the SCR consistently
collects information on religious groups that allows
us to conduct this type of analysis and identify pat-
terns of the disease in specific groups.
An important limitation of this study is that deaths are
not prostate cancer-specific mortality as SCR only col-
lects information on all-cause mortality. This might bias
our results by overestimating the prostate cancer deaths.
However, it is likely that most of deaths are due to pros-
tate cancer as they were diagnosed at advanced stages
(75.8% stage IV at diagnosis). A study conducted in the
US SEER registry demonstrated that including those
with unknown or undocumented causes of death as
prostate-cancer specific deaths led to very little change
in the 5-year survival estimation, particularly for those
diagnosed at later stages, suggesting that prostate cancer
cases diagnosed at later stages are likely to die from their
disease rather than from another cause [37]. We could
have used data from death certificates from the Thai
Ministry of Health to identify prostate cancer specific
deaths. However, the quality of death certificates is poor
in Thailand [38]. Another limitation of this study is that
the number of undetected cases are unknown due to
distant communities that may have poor access to health
centers, but the capture rate for prostate cancer in
Songkhla has been very high. One more limitation is
that complete adjustment for stage and grade was not
possible because of the large number of unknowns. To
address this limitation we conducted sensitivity analyses
where we imputed missing stage and grade. The multiple
imputation analysis showed similar results for the risk of
death between Buddhists and Muslims. In addition, lack
of adjustment for other prognostic factors such as socio-
economic status, smoking, comorbidities, may still lead
to residual confounding in our results.
Conclusions
Muslim men had a higher risk of death after diagnosis of
prostate cancer compared to Buddhist men. In contrast
with Buddhists, prostate cancer survival has remained
























3.0 77.9% 61.0% 30.5% 6.1 75.0% a a
2000–
2004
4.3 86.2% 71.6% 43.2% 3.1 74.7% 56.1% 30.0%
2005–
2009
3.8 78.9% 65.4% 42.2% 3.4 76.3% 61.8% 21.8%
2010–
2014
4.4 83.6% 71.6% 45.1% 2.6 75.5% 58.2% a
aUnable to calculate




Model 1: Model 2:
Person-years Calendar period Age Person-years Calendar period Age
HR (95%CI) HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI)
Buddhists 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)
Muslims 1.31 (1.00, 1.72) 1.27 (0.97, 1.66) 1.31 (1.00, 1.72) 1.27 (0.97, 1.67) 1.24 (0.94, 1.63) 1.25 (0.95, 1.64)
Model 1: Adjusted by age
Model 2: Adjusted by age, stage and grade
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constant in Muslims even after the introduction of
universal health care access. It is important to under-
stand what risk factors may underlie the poorer survival
observed in Muslims to design targeted interventions in
both populations.
Additional file
Additional file 1: Table S1. Overall stage distribution and by religious
groups comparing observed vs imputed data. Table S2. Hazard ratios for
death of prostate cancer by religious groups after partitioning follow up
time. (DOCX 21 kb)
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